New diagnostic tool could simplify low sodium treatment for blood pressure patients
NCT ID NCT06381934
First seen Jan 09, 2026 · Last updated Jun 19, 2026 · Updated 19 times
Summary
This study tests whether two new measurements, aSID and ChU, can help doctors better diagnose and treat low sodium levels in hospitalized patients taking thiazide diuretics for high blood pressure. Researchers will compare outcomes in 136 patients randomly assigned to either standard care or treatment guided by these new indices. The goal is to see if the new approach works as well or better than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THIAZIDE ASSOCIATED HYPONATREMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Diagnostic indices (aSID and ChU) used to guide therapy decisions
What this could lead to
If successful, this could make diagnosing and treating low sodium faster and more accurate for patients on thiazide diuretics, potentially reducing complications.
What could go wrong
This is a small, early-stage study (136 participants) focused on diagnostic accuracy, not a treatment itself. The new method may not outperform standard care in real-world settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.